51226-84-7 Usage
Uses
Used in Pharmaceutical Industry:
2-(4-pyridyl)thiazolidine-4-carboxylic acid is used as a pharmaceutical compound for its potential antioxidant properties, which may contribute to the development of treatments for oxidative stress-related conditions.
Used in Therapeutic Applications for Diabetes:
In the field of diabetes treatment, 2-(4-pyridyl)thiazolidine-4-carboxylic acid is being explored as a potential therapeutic agent that could help manage or treat the condition, possibly through its interaction with biological targets relevant to diabetes pathophysiology.
Used in Anti-inflammatory Treatments:
2-(4-pyridyl)thiazolidine-4-carboxylic acid is considered for use as an anti-inflammatory agent, leveraging its potential to modulate inflammatory pathways and provide relief in conditions characterized by inflammation.
Used in Synthesis of Other Pharmaceutical Compounds:
As a key intermediate in chemical synthesis, 2-(4-pyridyl)thiazolidine-4-carboxylic acid is utilized in the creation of other pharmaceutical compounds, contributing to the development of new drugs with diverse therapeutic applications.
Further research is necessary to fully understand the extent of 2-(4-pyridyl)thiazolidine-4-carboxylic acid's capabilities and to optimize its use in various medical and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 51226-84-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,2,2 and 6 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 51226-84:
(7*5)+(6*1)+(5*2)+(4*2)+(3*6)+(2*8)+(1*4)=97
97 % 10 = 7
So 51226-84-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2O2S/c12-9(13)7-5-14-8(11-7)6-1-3-10-4-2-6/h1-4,7-8,11H,5H2,(H,12,13)
51226-84-7Relevant academic research and scientific papers
THIAZOLIDINECARBOXYLIC ACID AMIDE DERIVATIVES AND THEIR THERAPEUTIC USES
-
, (2008/06/13)
Thiazolidinecarboxylic acid amides having combined antiallergic and antiasthmatic activities with an antagonist activity against platelet Activating Factor and having the following general formula (I) STR1
Saturated heterocyclic carboxamide derivatives
-
, (2008/06/13)
A saturated heterocyclic carboxamide derivative of the following general formula (I) and salts thereof which have platelet activating factor (PAF) antagonizing activity. STR1
